AMBENYL Drug Patent Profile
✉ Email this page to a colleague
When do Ambenyl patents expire, and what generic alternatives are available?
Ambenyl is a drug marketed by Forest Labs and is included in one NDA.
The generic ingredient in AMBENYL is bromodiphenhydramine hydrochloride; codeine phosphate. There are two drug master file entries for this compound. Additional details are available on the bromodiphenhydramine hydrochloride; codeine phosphate profile page.
Summary for AMBENYL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 136 |
Patent Applications: | 6,336 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMBENYL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AMBENYL
US Patents and Regulatory Information for AMBENYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Forest Labs | AMBENYL | bromodiphenhydramine hydrochloride; codeine phosphate | SYRUP;ORAL | 009319-006 | Jan 10, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |